BioNTech SE Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio24.403.625.321055.70
Forward P/E67.818.278.0710.17
P/S Ratio9.595.941.972.8833.27
P/B Ratio1.361.121.704.6011.70
Price/Tangible Book1.451.191.724.6813.21
Price/FCF4.432.5871.83
Price/OCF127.044.232.5261.54
Enterprise Value Ratios
EV/Revenue3.142.041.282.7731.59
EV/EBITDA7.041.843.53
EV/EBIT8.041.853.54
EV/FCF1.521.6769.01
Profitability & Returns
Return on Equity (ROE)-0.03%0.05%0.59%1.55%0.02%
Return on Assets (ROA)-0.04%0.03%0.38%1.02%-0.13%
Return on Invested Capital (ROIC)-0.38%0.15%1.06%1.96%-2.06%
Return on Capital Employed (ROCE)-0.06%0.05%0.59%1.20%-0.19%
Leverage & Solvency Ratios
Debt/Equity0.010.010.010.030.17
Debt/EBITDA0.190.020.02
Debt/FCF0.040.020.40
Liquidity Ratios
Current Ratio7.459.437.434.332.75
Quick Ratio7.269.127.194.152.50
Efficiency Ratios
Asset Turnover0.120.170.892.090.31
Inventory Turnover1.691.506.3610.281.56
Yield & Distribution Ratios
Earnings Yield-0.03%0.04%0.28%0.19%0.00%
FCF Yield0.00%0.23%0.39%0.01%-0.01%
Buyback Yield0.01%0.03%0.04%-0.05%-0.17%